Items where Author is "Nomikos, N."

Number of items: 5.
Article
  • Cost-effectiveness analysis of filgotinib as a first-line treatment for biologic-naive patients with Ulcerative Colitis in Greece. Nomikos, N. and Naoum, P. and Athanasakis, Kostas and Kyriopoulos, I
  • Cost-effectiveness analysis of filgotinib versus tofacitinib as first-line treatments for rheumatoid arthritis in Greece. Nomikos, N. and Naoum, P. and Athanasakis, K. and Kyriopoulos, I
  • EE477 A budget impact analysis of introducing filgotinib for the treatment of rheumatoid arthritis in Greece. Nomikos, N. and Naoum, P. and Athanasakis, K. and Kyriopoulos, I
  • EE478 A budget impact analysis of introducing filgotinib as a first-line treatment for moderate to severe ulcerative colitis in Greece. Nomikos, N. and Naoum, P. and Athanasakis, K. and Kyriopoulos, I
  • HPR240 A rapid review of key challenges and success factors in implementing managed entry agreements for pharmaceuticals:lessons for Greece. Zisis, K. and Karampli, E. and Nomikos, N. and Agorastos, I and Naoum, P. and Tsiantou, V and Kyriopoulos, I and Pavi, E.